Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash Flows from Operating Activities
Net (loss) income	$ (575,434)	$ 325,775
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation & Amortization	82,515	110,203
Operating lease expense	73,774	37,722
Changes in operating assets and liabilities:
Other receivables	(27,792)	63,860
Prepayments	(51,168)	(49,361)
Due from related parties	73,551	(12,274)
Accounts payable	(212,738)	(113,289)
Deferred revenue	288,535	(128,719)
Accrued expenses	(5,925)	(6,626)
Due to related parties	(32,649)	(15,521)
Operating lease	(24,082)
Other payables		(35,309)
Other current liabilities	(26,468)	(83,311)
Net cash (used in) provided by operating activities	(437,881)	93,150
Cash Flows from Investing Activities
Purchase of property, plant and equipment	(30,363)	(29,454)
Net cash used in investing activities	(30,363)	(29,454)
Effect of exchange rate fluctuation on cash and cash equivalents	50,404	(11,613)
Net (decrease) increase in cash and cash equivalents	(417,840)	52,083
Cash and cash equivalents, beginning of period	1,642,721	1,404,042
Cash and cash equivalents, end of period	1,224,881	1,456,125
Supplemental disclosure of cash flow information
Cash paid for income taxes	20,103	186,605
Cash paid for interest expense
Supplemental disclosure of non-cash activities
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 69,830